Inhibition of wasting and protein degradation of mammalian muscl

Details Inhibition of wasting and protein degradation of mammalian muscl Inhibition of wasting and protein degradation of mammalian muscl

1990-06-28

1991-09-03

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

A61K 3165

Patent

active

050455389

ABSTRACT:
A method for treating mammals suffering from skeletal muscle wasting and/or intracellular protein degradation of skeletal muscle systems by administering to the mammal an amount of tetracycline which results in a significant reduction of the muscle wasting and protein degradation is disclosed. In addition, there is also disclosed a method of increasing the protein content of skeletal muscle systems of mammals by administration of tetracyclines. The tetracyclines useful in the above methods are both antimicrobial and non-antimicrobial. In a preferred embodiment, the method of treatment utilizes a non-antimicrobial tetracycline such as dedimethylaminotetracycline (CMT).

REFERENCES:
patent: 4666897 (1987-05-01), Golub et al.
patent: 4704383 (1987-11-01), McNamara et al.
patent: 4925833 (1990-05-01), McNamara et al.
patent: 4935411 (1990-06-01), McNamara et al.
patent: 4935412 (1990-06-01), McNamara et al.
Gorray et al., in Metabolism 39, No. 2, 109-116 (1990).
Golub et al., "Further Evidence That Tetracyclines Inhibit Collagenase Activity in Human Crevicular Fluid and from Other Mammalian Sources", J. Periodont. Res. 20, 12-23 (1985).
Greenwald et al., "Direct Detection of Collagenase and Gelatinase in Particular Tissue from Adjuvant Arthritic Rats: Inhibition by Tetracyclines and Potential Amelioration of Bone Destruction", Abstract, Transactions of the Orthopedic Research Society, vol. 15, p. 270 (1990).
The Chemistry of Tetracyclines, (L. A. Mitscher, ed.) Chapter 6, pp. 165-218 (1978).
Golub et al., "Tetracyclines (TCs Inhibit Mealloproteinase (MPs): In Vitro Effects of Arthritic and Diabetic Rats, and New In Vitro Studies", Abstract, Matrix Metalloproteinase Conference, p. 43, Sep. 1989.
Sipos et al., "The Effect of Collagenase Inhibitors on Alveolar Bone Loss Due to Periodontal Disease in Desalivated Rats", Abstract, Matrix Metalloprotenase Conference, p. 43, Sep. 1989.
Breedveld et al., "Suppression of Collagen and Adjuvant Arthritis by a Tetracycline", Abstract, Northeastern Regional Meeting of the Amer. Rheum. Assoc., p. 17, Oct. 1987.
Elewski et al., "In Vivo Suppression of Neutrophil Chemotaxis by Systemically and Topically Administered Tetracycline", Journal of the American Academy of Dermatology 8, 807-812 (1983).
Skinner et al., "Tetracycline in the Treatment of Rheumatoid Arthritis--a Double Blind Controlled Study", Arthritis and Rheumatism 14, 727-732 (1971).
Plewig et al., "Anti-Inflammatory Effects of Antimicrobial Agents: An In Vivo Study", Journal of Investigative Dermatology 65, 532-536 (1975).
White, J. E., "Minocycline for Dystrophic Epidermolysis Bullosa", Lancet, 966 (1989).
Delaisse et al., "A New Synthetic Inhibitor of Mammalian Tissue Collagenase Inhibits Bone Resorption in Culture", Biochemical and Biophysical Research Communications 133, 483-490 (1985).
Cowen et al., "Monensin Inhibits Collagenase Production in Osteoblastic Cell Cultures and Also Inhibits Both Collagenase Release and Bone Resorption in Mouse Calvaria Cultures", Biochemistry International 11, 273-280 (1985).
Wong et al., "Oral Ibuprofen and Tetracycline for the Treatment of Resistant Acne Vulgaris", Journal of the American Academy of Dermatology 11, 1076-1081 (1984).
Funt, L. S., "Oral Ibuprofen and Minocycline for the Treatment of Acne Vulgaris", Journal of the American Academy of Dermatology, 13, 524-525 (1985).
Golub et al., "In Vivo Crevicular Leukocyte Response to a Chemotactic Challenge: Inhibition by Experimental Diabetes", Infection and Immunity 37, 1013-1020 (1982).
Yu et al., "Serum Levels of Chemically-Modified Tetracycline (CMT): a Composition to Tetracycline (TC)", J. Dent. Res. 69, 245 (Special Issue), IADR Special Abstract No. 1092.

Affiliated with

Also associated with

Rating

Inhibition of wasting and protein degradation of mammalian muscl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of wasting and protein degradation of mammalian muscl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of wasting and protein degradation of mammalian muscl will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1009469